Tribulations and (clinical) trials in cystic fibrosis
- 1 March 2021
- journal article
- editorial
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (2), 188-190
- https://doi.org/10.1016/j.jcf.2020.12.017
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutationJournal of Cystic Fibrosis, 2020
- Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosisJournal of Cystic Fibrosis, 2020
- Factors influencing clinical trial participation for adult and pediatric patients with cystic fibrosisJournal of Cystic Fibrosis, 2020
- Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis – a randomized trialJournal of Cystic Fibrosis, 2020
- New therapies for people with CF in the CFTR modulator worldJournal of Cystic Fibrosis, 2020
- Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus viewJournal of Cystic Fibrosis, 2020
- Building global development strategies for cf therapeutics during a transitional cftr modulator eraJournal of Cystic Fibrosis, 2020
- Inhalation of Moli1901 in Patients With Cystic FibrosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007